Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study evaluated the safety and effectiveness of AVP-786 for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Cerritos
Efficiency of the French Translation Program:Social Cognition and Interactive Training (SCIT) of Negative Symptoms in Schizophrenia
This study has finished and is no longer accepting participants.
In ClermontElectroconvulsive Therapy for Treatment Refractory Schizophrenia - A Randomized, Double-blinded, Sham-controlled Study
This study ended early.
Location not clearly listed
Pretreatment Electroencephalogram (EEG) May Predict Electroconvulsive Therapy(ECT) Effect in Schizophrenia
This study has finished and is no longer accepting participants.
In ShanghaiThis study has finished and is no longer accepting participants.
In UtrechtDeveloping an Intervention Strategy to Enhance Motivation in Recent Onset Schizophrenia
This study ended early.
In San FranciscoEnhancing the Prospective Prediction of Psychosis
Read the official source — NCT00291200Enhancing the Prospective Prediction of Psychosis
This study has finished and is no longer accepting participants.
Multiple locations, including New HavenEstimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders.
This study has finished and is no longer accepting participants.
In GrenobleEuropean Long-acting Antipsychotics in Schizophrenia Trial
This study has finished and is no longer accepting participants.
Multiple locations, including InnsbruckA Randomized, Open-Label, Parallel, Single-Dose Study to Evaluate the Pharmacokinetic Characteristics of LY03010 Process 1 and Process 2 Drug Product Versus INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
This study has finished and is no longer accepting participants.
In BerlinEvaluation of Metamemory in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Clermont-FerrandA Placebo-Controlled Study to Evaluate the Effect of a Single Dose of TAK-058 and Ondansetron on P50 Auditory Gating in Subjects With Stable Schizophrenia
This study ended early.
In St LouisWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.